News zum Sektor Mischkonzerne aus Schweden

 

In accordance with the decision by the extraordinary general meeting on 24 September 2021, the Nomination Committee shall consist of four members. The Nomination Committee for the Annual General Meeting 2026 has been appointed based on the shareholdings as of 31 August 2025 and in accordance with the instructions for the Nomination Committee. The Nomination Committee is composed of: Liv Gorosch (Chairman), appointed by the A-shareholders, Ronnie Bergström, appointed by the A-shareholders, Dick Bergqvist, appointed by AMF, and Oscar Bergman, appointed by Swedbank Robur Fonder. In...

Storskogen Group AB (publ) (“Storskogen”) successfully issues senior unsecured bonds of SEK 1,000 million to finance the early redemption of outstanding bonds due in 2025 and for general corporate purposes. Storskogen has successfully issued senior unsecured bonds of SEK 1,000 million under a framework of SEK 2,000 million (the “Bond Issue”). The bonds will carry a floating interest rate of 3m Stibor + 265 basis points per annum and mature in April 2030. The Bond Issue is expected to settle on 7 October 2025 and the proceeds from the Bond Issue will be used to finance the early redemption...

Storskogen Group AB (publ) (“Storskogen”) has mandated banks to arrange investor meetings to explore the possibility of issuing SEK denominated senior unsecured bonds with an expected volume of SEK 1,000 million, and announces a conditional notice of early redemption of outstanding bonds due in 2025. Storskogen has mandated Danske Bank, DNB Carnegie, Nordea, SEB and SB1 Markets to arrange a series of fixed income investor meetings starting on 22 September 2025, to explore the possibility of issuing senior unsecured bonds with a floating interest rate and a 4.5-year tenor (the “New Bonds”). A...

STOCKHOLM, Sept. 19, 2025 /PRNewswire/ -- EQT AB's Nomination Committee for the Annual Shareholders' Meeting 2026 has been appointed based on the ownership structure as of 31 August 2025. The Nomination Committee consists of Jacob Wallenberg (Chairperson), appointed by Investor AB Cynthia......

The members of the Nomination Committee for the Husqvarna AB 2026 Annual General Meeting (“AGM”) have now been appointed, as follows: Petra Hedengran (Chair, appointed by Investor AB) Louise Lindh (appointed by L E Lundbergföretagen AB) Fredrik Ahlin (appointed by If Skadeförsäkring AB) Oskar Börjesson (appointed by Livförsäkringsbolaget Skandia) Torbjörn Lööf (Board Chair of Husqvarna AB)   Such appointments have been made in accordance with the rules last approved by the Husqvarna AB AGM. Those rules state that the Nomination Committee shall consist of one representative...

In 2020 Sandvik AB's Annual General Meeting adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprised of members appointed by each of the four principal shareholders in terms of votes on the last banking day of August, as well as the Chairman of the Board (convenor). The Nomination Committee has now been appointed and consists of the following members: · Fredrik Lundberg, AB Industrivärden, Chairman of the Nomination...

Nacka, Sweden, September 16, 2025: The following representatives of Atlas Copco AB's shareholders, together with the Chair of the Board, Hans Stråberg, will form the nomination committee for the Annual General Meeting 2026. Representatives: Petra Hedengran, Investor AB (Chair of the Nomination Committee) Joachim Spetz, Swedbank Robur Fonder AB Helen Fasth Gillstedt, Handelsbanken Fonder AB Filippa Gerstädt, Nordea Funds AB The Annual General Meeting of Atlas Copco AB will be held on April 28, 2026. Shareholders who wish to submit proposals to the nomination committee can do...

Investor AB's Nomination Committee for the Annual General Meeting 2026 has been appointed based on the ownership structure as of August 29, 2025. The Nomination Committee consists of: Leif Johansson, Wallenberg Foundations Katarina Romberg, AMF Tjänstepension och AMF Fonder Magnus Carlsson, SEB Foundation Peder Hasslev, Alecta Jacob Wallenberg, Chair of the Board of Investor AB Shareholders having appointed members to the Nomination Committee represent approximately 65 percent of the voting rights for all shares of Investor AB. The Annual General Meeting of Investor AB will be...

In 2024, an Annual General Meeting of Alleima AB adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprised of members appointed by each of the four principal shareholders in terms of votes on the last banking day of August, as well as the Chairman of the Board (convenor). The Nomination Committee has now been appointed and consists of the following members: ―      Fredrik Lundberg, Industrivärden (Chairman of the Nomination...

Taiwan's bid to challenge global telecom incumbents with 5G Open RAN (O-RAN) is faltering, as network outages in automated factories undermine trust and local vendors struggle to monetize investments. Once championed as a bridge for Taiwan's IT sector to break into communications technology and loosen the grip of Nokia, Ericsson, and Siemens, O-RAN's commercial promise is now in doubt. Industry leaders and analysts see the emerging concept of AI-RAN as the sector's potential reset....

Pipeline expansion: Company advances first-in-class clinical pipeline to address large unmet medical needs in Atopic Dermatitis, Asthma, Inflammatory Bowel Disease, and Obesity Platform scale: Company doubles down on its platform, delivering 12+ development candidates from life's chemistry 4× faster and 10× cheaper than industry averageBOULDER, Colo.--(BUSINESS WIRE)--#AI--Enveda, a clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life's chemistry, today announced three major milestones: the close of its $150 million oversubscribed Series D financing, enrolling of the first patient in a Phase 1b clinical trial for lead program ENV-294 in atopic dermatitis, and the appointment of former Pfizer Chief Scientific Officer and President of Worldwide R&D, Dr. Mikael Dolsten, to its Board of Directors. The round was led by Premji Invest with participation from new and existing investors Baillie Gifford, Kinnevik, Lingotto Investme...

Analysten bleiben für die Roko-Akie zurückhaltend und empfehlen mehrheitlich Halten oder Verkaufen. Gleichzeitig sorgt die klangähnliche Roku für potenzielle Verwechslungen bei Anlegern....

Storskogen has acquired approximately 93 percent of the shares in Carry Gently Limited (“Carry Gently”), a leading provider in transport of high value, fragile equipment, based in the United Kingdom. The company generated sales of approximately GBP 3.4 million in 2024, corresponding to around SEK 45 million. The acquisition increases Storskogen's exposure to profitable and niche transport companies. With over 30 years of experience, Carry Gently is a specialised logistics partner for customers with complex, high value and fragile products. The company's core customer segments are active in...

Funding will advance Strand's pipeline and mission to bring targeted, next-generation mRNA therapies to patients First-in-human solid tumor Phase 1 data from lead program, STX-001, was recently presented at 2025 ASCO Annual MeetingBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced $153M Series B funding led by Kinnevik, with new investors Regeneron Ventures, ICONIQ, Amgen Ventures, Alderline Group (the family office of Alex Gorsky), JIC-VGI, LG Technology Ventures, and Gradiant Corporation, with continued participation from existing investors including FPV Ventures, Playground Global, Eli Lilly and Company, ANRI, and Potentum. To date, Strand has raised over $250M. As part of the financing, Ala Alenazi, Ph.D., of Kinnevik, will join the company's Board of Directors. The funding will advance Strand's pipeline, led by STX-001, a programmable mRNA therapy that expresses the cytokine interleukin-12 (IL-12) directly from the tumor microenvironm...

Storskogen has acquired LEP AG (“LEP”), a Swiss-headquartered company offering digital healthcare documentation solutions. The company generated sales of CHF 6.1 million in 2024, approximately SEK 72 million, with about 80 percent of its revenues stemming from recurring subscriptions. The acquisition is in line with Storskogen's communicated strategy to increase exposure to sectors that combine solid long-term growth and lower sensitivity to economic cycles. Digitalisation and health are two investment themes that Storskogen has pinpointed. Christer Hansson, CEO of Storskogen: “LEP...

On 12 August 2025 at 07:00 (CEST), Storskogen announces its interim report for the second quarter 2025. In connection with the announcement, Christer Hansson, CEO, and Lena Glader, CFO, will hold a presentation followed by a Q&A session. The presentation will be conducted in English and starts at 09:00 (CEST). The presentation and the subsequent Q&A can be followed via webcast or telephone conference. For participation via webcast, please use the following link: https://storskogen-group.events.inderes.com/q2-report-2025/register If you wish to participate via telephone conference,...

Ericsson to supply network equipment for SoftBank's low, mid, and high bands Ericsson will contribute to SoftBank's 4G and 5G networks enhancement and expand further expansion of 5G Standalone coverage STOCKHOLM, July 31, 2025 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) has strengthened its......

Ericsson to supply network equipment for SoftBank's low, mid, and high bands Ericsson will contribute to SoftBank's 4G and 5G networks enhancement and expand further expansion of 5G Standalone coverage STOCKHOLM, July 31, 2025 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) has strengthened its......

BOSTON & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has promoted Aisling Malone to Deputy Senior Executive Officer and Head of Customer & Broker Engagement, and Joe Saab to Vice President, Head of Executive & Professional Lines, in the Middle East. “These leadership promotions are in line with our ongoing growth and evolution in the region. Aisling will continue to bring her technical acumen and leadership to our underwriting, with expanded responsibility for third party lines. She also takes the reins of our newly created Customer & Broker Engagement function, focused on further strengthening our relations with ceding companies, producers and customers,” said Neeraj Yadvendu, SEO & Head of Middle East, BHSI. “Joe has been instrumental in building our E&P practice from the start and will now lead us to the next level of success in the marketplace.” Aisling joined BHSI in 2018 and most recently served as Vice President and Hea...

Dass es mit der Investor AB Aktie ein europäisches Pendant zu Berkshire Hathaway gibt, wissen nur wenige. Der Artikel Investor AB: Die europäische Berkshire mit jährlich 9 % Dividendenwachstum ist zuerst erschienen auf Aktienwelt360....